Target intelligence / Profile preview

Integrins and dystroglycan on muscle fibers and nerve cells

Molecular classification
Receptor, Cell adhesion molecule, Glycoprotein
01

Overview

Integrins and dystroglycan are the two primary classes of transmembrane receptors that anchor muscle fibers and nerve cells to the extracellular matrix (ECM) (UniProt P55051, Q13683). In skeletal muscle, the alpha7beta1 integrin and the dystroglycan complex (comprising alpha and beta subunits) serve as critical mechanical links between the laminin-rich basement membrane and the internal cytoskeleton (Michele & Campbell, 2003). These receptors are essential for maintaining the structural integrity of the sarcolemma during muscle contraction and for mediating signal transduction pathways that regulate cell survival and differentiation (Belkin & Burridge, 2000). Mutations or deficiencies in these proteins, or the enzymes responsible for their post-translational modification (particularly for dystroglycan), lead to various forms of muscular dystrophy, such as Duchenne and congenital muscular dystrophies, as well as neurological disorders like Walker-Warburg syndrome (UniProt P55051). In nerve cells, these molecules are involved in the formation of the neuromuscular junction and the maintenance of the blood-brain barrier. Therapeutic strategies often focus on upregulating integrin expression to compensate for the loss of the dystrophin-glycoprotein complex or restoring proper glycosylation of alpha-dystroglycan to maintain muscle stability (Rooney et al., 2012).

Other names
Laminin receptorsDystrophin-associated glycoprotein complex componentsDGC componentsAlpha7beta1 integrinDystroglycan 1 (DAG1)Integrin alpha-7 (ITGA7)
02

Mechanism of action

Restoration of the mechanical linkage between the extracellular matrix and the intracellular cytoskeleton to prevent sarcolemmal rupture and muscle fiber degeneration.

03

Biological functions

Cell adhesionSignal transductionMuscle contractionStructural integritySynaptic maintenance
04

Disease associations

Muscular dystrophyDystroglycanopathyCongenital muscular dystrophyWalker-Warburg syndromeCancer
05

Safety considerations

Off-target effects in non-muscle tissuesImmunogenicity of recombinant proteinsComplexity of achieving correct post-translational glycosylation in gene therapy
06

Interacting drugs

Laminin-111

2 more in the full profile.

07

Biomarkers

Alpha-dystroglycan glycosylation (matriglycan)Integrin alpha-7 expression levelsSerum creatine kinase (CK)

Beyond the preview

Go deeper on Integrins and dystroglycan on muscle fibers and nerve cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrins and dystroglycan on muscle fibers and nerve cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call